Order your free hard copy by adding to cart or you can download an electronic copy for free using the link below
Order your free hard copy by adding to cart or you can download an electronic copy for free using the link below
The article examines public-health warnings concerning products marketed as “Cat’s Claw” that were found to contain undisclosed opioid-active compounds. Utah testing identified mitragynine pseudoindoxyl and MGM-15 in Buzzers-brand tablets associated with severe health incidents and a death investigation. It distinguishes these products from genuine cat’s claw, a botanical supplement not known to produce opioid effects. The article describes potential overdose and dependence risks, warning signs, naloxone use, and recommended actions for consumers, retailers, and health professionals. It also explains the federal scheduling of several related compounds and emphasizes that findings from tested products should not be generalized to every product bearing the Cat’s Claw name.
This project is funded under a grant contract with the State of Tennessee,
Department of Mental Health and Substance Abuse Services.


Address
1321 Murfreesboro Pike #155
Nashville, TN 37217
United States
615-780-5901